Prolastin-C Liquid 1000 mg/20mL (Alpha1-Proteinase Inhibitor (Human) INJECTION, SOLUTION) 1000 mg/20mL

Prolastin-C Liquid 1000 mg/20mL is an intravenous solution containing Alpha1-Proteinase Inhibitor (Human). This medication is used to manage certain conditions related to proteinase inhibition. Learn more about its uses and effects.

Strength

1000 mg/20mL

Pack Size

1 VIAL in 1 CARTON (13533-705-31) / 10 mL in 1 VIAL (13533-705-32)

Manufacturer / TM Owner

GRIFOLS USA, LLC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Prolastin-C Liquid is primarily used to augment the proteinase inhibitor activity in individuals with a deficiency. This medication is often prescribed for conditions where proteinase inhibition is necessary. It is administered intravenously to help manage symptoms associated with these deficiencies.

Side Effects

Common effects of Prolastin-C Liquid may include reactions at the injection site, such as redness or swelling. Some individuals might experience flu-like symptoms, including fever or chills. These effects vary and should be discussed with a healthcare provider.

Precautions & Warnings

Prolastin-C Liquid should be handled with care, ensuring proper storage and administration. It is important to follow the prescribed guidelines for intravenous use. Always consult a healthcare professional for personalized advice.

Avoid Interactions

Prolastin-C Liquid may interact with other medications, particularly those that affect the immune system or blood clotting. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions.

Frequently Asked Questions

Prolastin-C Liquid is used to augment proteinase inhibitor activity in individuals with a deficiency, helping to manage related conditions.

Prolastin-C Liquid is administered intravenously, typically by a healthcare professional.

Common effects may include reactions at the injection site, such as redness or swelling, and flu-like symptoms.

Yes, Prolastin-C Liquid may interact with medications that affect the immune system or blood clotting.

Proper storage and administration guidelines should be followed, and personalized advice should be sought from a healthcare provider.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.